MAREK'S
# Years volume Title Author Page
992 66 15 Some Preliminary Studies on Marek's Disease Calnek 17
993 66 15 Marek's Disease Field Evidence Hughes 18
994 67 1 The Epidemiology Of Acute Marek's Leukosis Schmittle, S. 9
995 67 1 Problems Of Control Of Marek's Disease Hughes, W. 13
996 67 1 Excretion Of Marek's Disease Agent Kenzy, S. 8
997 67 16 Leukosis Panel-Excretion of Marek's Disease Agent Kenzy 22
998 67 1 Studies On Marek's Disease Agents Witter, Richard 5
999 67 16 Leukosis Panel-The Epidemiology of Acute Marek's Disease Schmittle 18
1000 67 16 Leukosis Panel-Maintenance of Marek's Disease Agent in Cell Culture Witter 22
1001 68 2 Herpesvirus As The Cause Of Marek's Disease Nazerian, Keyvan none
1002 68 17 Investigating Diagnostic Procedures for Marek's Disease Bankowski 5
1003 68 17 Strain Resistance to Marek's Disease Cole 2
1004 68 2 Genetic Difference In Resistance To A Marek's Disease Agent Cole, Randall none
1005 68 17 Highlights of Research on the Etiology of Marek's Disease Nazerian 3
1006 68 2 Investigating Diagnostic Procedures For Marek's Disease Bankowski, R. none
1007 69 3 Control Of Marek's Disease Hughes, Walter 60
1008 69 18 Some Observations of Marek's Disease on Multiple Brooding Chicken Ranches Clark 59
1009 69 3 Recent Advances in Marek's Disease Research Purchase, H. 57
1010 69 3 Differentiation Between Marek's Disease (MD) And Lymphoid Leukosis (LL) Helmboldt, C. 58
1011 69 18 Marek's Disease and Avian Encephalomyelitis Hughes 60
1012 69 18 Recent Advances in Marek's Disease Research Purchase 57
1013 69 3 Some Observations Of Marek's Disease On Multiple Brooding Chicken Ranches Clark, D. 59
1014 69 18 Differentiation Between Marek's Disease (MD) and Lymphoid Leukosis (LL) Helmboldt 58
1015 70 19 Studies on the Character of Marek's Disease Infection Calnek 94
1016 70 19 Field Control of Leukosis and Marek's Disease Smith 79
1017 70 19 Herpesvirus Isolates-Characteristics and Controls Bankowski 81
1018 70 19 Chicken Dander and Marek's Disease Beasley 89
1019 70 19 Pathogenesis of Natural and Experimental Infection with the UA-1 Isolate of the Marek's Disease Agent Beasley 88
1020 70 19 Marek's Disease: The Rationale Behind Potential Control Methods Calnek 95
1021 70 19 Developing and Testing of a Marek's Disease Vaccine Burmester 90
1022 71 20 Recent Findings on Resistance to Marek's Disease Bankowski 64
1023 71 20 Comments on Vaccination Studies for Marek's Disease Kenzy 41
1024 71 20 Observations in the Laboratory and Field on Marek's Disease Olsen 39
1025 71 20 Observations on Marek's Disease Hughes 66
1026 71 20 Field Observations in California on Marek's Disease Immunization Holte 42
1027 71 20 Marek's Disease Immunization Procedures Zander 43
1028 72 21 Immunological Responsiveness in Marek's Disease-A Basis for Resistance? Calnek 31
1029 72 21 Studies on the Onset of Viremia and Spread of Mild Immunizing Strain of MD Virus of Chicken Origin Hill 22
1030 72 21 Operation Head Start-The Use of Preinoculated Chicks for Controlled Natural MD Exposure Zander 35
1031 73 22 Marek's Disease: Viremia and Antibody Studies in Vaccinated and Non-Vaccinated Birds Coles 59
1032 73 22 Control of Marek's Disease in Broilers Sharma 47
1033 73 22 Abstract-Resistance to Marek's Disease Peterson 47
1034 73 22 Head Start and Concurrent Infection of a Small Percentage of Birds With a Naturally Occurring Mild Marek's Disease Virus To Reduce "Leukosis" Condemnations in Broilers Zander 48
1035 73 22 The Role of MDHV in Temporary Paralysis Kenzy 43
1036 74 23 Marek's Control-A Long-Term Observation Balch 7
1037 74 23 Investigation of A Suspected Marek's Disease Vaccine Failure Butterweck 10
1038 74 23 Immunity Induced By Vaccination Against Marek's Disease Spencer 18
1039 74 23 Field Experiences with Marek's Disease Control Using A Mild Marek's Disease Virus Dunsing 12
1040 74 23 Is Maternal Antibody A Problem In Marek's Disease Vaccination? Calnek 15
1041 75 24 Aerosol Administration of Turkey Herpesvirus Vaccine Kleven 21
1042 75 24 Marek's Disease Vaccines: Cosmetic or Not Sevoian 18
1043 75 24 Some Characteristics of Lyophilized HVT And Its Field Application Gaudry 7
1044 75 24 Thermolability of Cell-Associated Herpesvirus of Turkeys in Vaccines Against Marek's Disease of Chickens Kaleta 15
1045 75 24 Mechanisms of Marek's Disease Immunity-Studies and Speculations Witter 19
1046 75 24 Comments on Marek's Disease Vaccines Zander 21
1047 75 24 Marek's Disease Virus Infection In Zoo Birds Cho 3
1048 75 24 Pathogenic Studies In Chickens On A Reo Virus Isolated From A Commercial Turkey Herpesvirus Vaccine Against Marek's Disease Kaleta 11
1049 76 25 An Evaluation of Research on Lymphoid Leukosis and Marek's Disease Purchase 2
1050 76 25 Influence of Physical and Chemical Factors on Survival of Marek's Disease Vaccine Virus Colwell 3
1051 76 25 Virologic Findings in Commercial Chicken Flocks Having MD Vaccine Breaks Cho 6
1052 77 26 Refection Of A Transplantable Marek's Disease Lymphoma In Normal Versus Immunologically Deficient Chickens Calneck 35
1053 77 26 HVT Viremia In Two Strains Of Vaccinated Chickens: Strain Difference And Effects of Vaccine Dose (Abstract) Cho 29
1054 78 27 Why Marek's Vaccines Protect Sharma 49
1055 78 27 Herpes Virus Of Turkey Vaccine: Viraemias In Field Flocks And In Experimental Chickens Riddell 43
1056 78 27 Prospects For The Differential Diagnosis Of Marek's Disease And Lymphoid Leukosis On The Basis Of Tumor Specific Criteria Neumann 44
1057 78 27 Possible Effects Of Avian Reovirus On The Development Of Marek's Disease Cho 43
1058 79 28 Update On Variant Marek's Disease Virus And Vaccine Breaks Witter 90
1059 79 28 Vaccination Against Marek's Disease Calneck 91
1060 79 28 Genetic Basis Of Transient Paralysis Caused By Marek's Disease Virus Schierman 88
1061 80 29 Differences Between Marek's Disease Virus Strains Calneck 185
1062 80 29 Limited Pathogenic Potential Of Marek's Vaccine (HVT) For Chickens And Turkeys Sharma 181
1063 80 29 Marek's Disease Vaccine Breaks Sharma 188
1064 80 29 Growth And Characterization Of, And Immunological Response Of Chicken To, A Cell Line Established From JMV Lymphoblastic Leukemia Sevoian 177
1065 80 29 Efficacy Of The Turkey Herpesvirus Vaccine In Chickens Challenged With Recently Isolated Marek's Disease Viruses Eidson 184
1066 80 29 Viral And Tumor Cell Immunity Of Chickens To Marek's Disease Sevoian 178
1067 81 30 Herpesvirus-Induced Atherosclerosis Fabricant 43
1068 81 30 Comparative Efficacy Studies With Two Cell-Associated Vaccines (CVI 988-Dutch And FC 126-USA) In Chickens Exposed To Virulent Marek's Disease Virus Maas 39
1069 81 30 Role Of Herpesvirus In Turkey Infertility-Recent Results Adldinger 35
1070 81 30 Selective Isolation And Identification Of Turkey Herpesvirus (HVT) From Chickens Dually Infected With HVT And Marek's Disease Virus Cho 37
1071 81 30 Potentiation Of HVT-Vaccinated Chickens Using An Immunoregulating Agent Sivanandan 32
1072 81 30 The Development Of An Effective control Of Marek's Disease In The Netherlands Maas 93
1073 81 30 The Increase Of Marek's Disease Outbreaks in Mexico Mireles 32
1074 82 31 Difference Between Oncogenic And Noncogenic Marek's Disease Virus In Feather Follicle Rangga-Tabbu 118
1075 82 31 Marek's Disease Vaccination Breaks Schat 119
1076 82 31 Virulent Marek's Disease Viruses From Vaccine Breaks Witter 117
1077 82 31 Experimental Studies On The Prophylactic Effect Of The Antiviral Agent Impacarzinum Against Marek's Disease Siegmann 122
1078 83 32 Reovirus Interference With Marek's Disease Vaccination Rosenberger 50
1079 83 32 Field Trials With A Bivalent Vaccine (HVT and SB-1) Against Marek's Disease Calnek 58
1080 83 32 Virus-Specific Lymphocyte Proliferation Of HVT-Vaccinated Chickens Sivanandan 60
1081 84 33 Results Of Field And Lab Studies On The Use Of SB-1 (Apathogenic HVC) And HVT Stewart 79
1082 84 33 Intracloacal And Intrabursal Vaccination Against Marek's Disease Ortiz 78
1083 84 33 Update On Recent Advances In Vaccination Against Marek's Disease Sharma 82
1084 85 34 Some New Concepts Of Marek's Disease Pathogenisis Calneck 67
1085 86 35 Immunization Of Chickens With JMV-1 Supernatant Against Marek's Disease Sevoian 220
1086 87 36 Marek's Disease Research-A Potpourri Calnek 36
1087 87 36 Update On Marek's Disease Vaccine, CV1-988 Clone C De Boer 25
1088 88 37 Marek's Disease Vaccination Strategies Employing Vaccines Of Three Avian Herpesvirus Serotypes De Boer 165
1089 88 37 Marek's Disease Viral Gene Expression In Tumor Cells And Transformed Cell Lines Lee 3
1090 89 38 Difficulty And Improvement In The Control Of Marek's Disease In Broiler Breeders Zanella 115
1091 91 40 Current status of in ovo vaccination against Marek's disease Wakenell, P. 283
1092 91 40 Errors in the management of M.D. vaccine in Mexican hatcheries Gomez, C. 102
1093 92 41 Update on USDA licensing requirements for Marek's disease vaccines (poster) Williams, T. 92
1094 92 41 New approaches to study cell-mediated immune responses to Marek's disease virus Schat, K. 60
1095 93 42 A recombinant HVT vaccine expressing Newcastle disease virus antigens protects chicks against a lethal Newcastle disease challenge Reynolds, D. 40
1096 93 42 Marek's disease research-present directions and future objectives Calnek, B. 60
1097 93 42 Comparative susceptibility of MSB-1 and CU-147 lymphoblastoid cell lines to several chicken infectious anemia viruses Lucio, B. 71
1098 93 42 Commercial broiler studies of Marek's disease vaccination in ovo Miles, A. 47
1099 93 42 Potency testing of Marek's disease vaccines containing ceftiofur sodium (poster) Schriemer, T. 97
1100 94 43 Influence of host genotype and type of challenge on lesions caused by a virulent strain of Marek's disease virus (AC-1) Spencer, J.L. 86
1101 94 43 The effect of mixing antibodies with Marek's disease vaccines Kinney, N. 96
1102 95 44 Effect of sarafloxacin on Marek's vaccine McCabe, M.W. 127
1103 95 44 The effects of acemannan on Marek's vaccine and challenge viremia Harrington, S. 57
1104 95 44 Efficacy and safety of a recombinant fowl pox-Marek's disease vaccine Kinney, N. 108
1105 95 44 Isolation of very virulent strains of Marek's disease virus from vaccinated chickens in Argentina Buscaglia, C. 53
1106 96 45 Interferon modulation of Marek's disease virus latency Calneck, B.W. 69
1107 96 45 Observations on a naturally occurring outbreak of Marek's disease in chickens and Coturnix quail Stedman, N.L. 138
1108 96 45 Control of Marek's disease in the U.S. and some other countries by the use of Marek's disease vaccine, Rispens strain Kumar, S. 74
1109 96 45 Field trial and efficacy of polyvalent Marek's disease vaccines combined with a live attenuated strain of Infectious Bursal Disease virus Sarma, G. 71
1110 96 45 Reproducibility of efficacy tests for Marek's disease vaccines Witter, R.L. 72
1111 96 45 Efficacy of Marek's vaccines in commercial broilers Montiel, E. 70
1112 97 46 Tumors In Turkeys And The Emergence Of Marek's Disease Malkinson, M. 31
1113 97 46 Protecting Chicken Flocks Against Virulent Marek's Disease Virus By Inoculating 5% Or Less Of The Flock With A Strain HN-1 Of Type 2 Naturally Occurring Apathogenic MDV At One Day Of Age Zander, D.V. 78
1114 97 46 Use of Marek's Vaccines-Protecting Our Future Rudd, H.K. 1
1115 98 47 Multiple Causes Of Marek's Disease Vaccination Failure In Australian Poultry Flocks Jackson, C.A.W. 49
1116 99 48 Quality assurance of Marek's disease vaccine use in hatcheries Jackson, C. 34
1117 99 48 Impact of V V Marek's disease on mortality and production in a multiple-age farm Lucio-Martinez, B. 55
1118 99 48 Protection of chickens against very virulent infectious bursal disease virus with a recombinant Marek's disease virus expressing IBDV VP2 antigen Tsukamoto, K. 49
1119 99 48 Behavior of a very virulent Marek's disease virus in two vaccinated commercial chicken flocks in Argentina Buscaglia, C. 105
1120 96 45 Reproducibility of efficacy tests for Marek's disease vaccines Witter, R.L. 72


Last Updated on 12/22/99
By Ralph A. Ernst